Inhaled indacaterol for the treatment of COPD patients with destroyed lung by tuberculosis and moderate-to-severe airflow limitation: results from the randomized INFINITY study

Inhaled indacaterol for the treatment of COPD patients with destroyed lung by tuberculosis and moderate-to-severe airflow limitation: results from the randomized INFINITY study

Cheong-Ju Kim,1 Hyoung-Kyu Yoon,2 Myung-Jae Park,3 Kwang-Ha Yoo,4 Ki-Suck Jung,5 Jeong-Woong Park,6 Seong Yong Lim,7 Jae Jeong Shim,8 Yong Chul Lee,9 Young-Sam Kim,10 Yeon-Mok Oh,11 Song Kim,12 Chul-Gyu Yoo13 1Department of Internal Medicine, National Health Insurance System Ilsan Hospital, Koyang,...

Full description

Bibliographic Details
Main Authors: Kim CJ, Yoon HK, Park MJ, Yoo KH, Jung KS, Park JW, Lim SY, Shim JJ, Lee YC, Kim YS, Oh YM, Kim S, Yoo CG
Format: Article
Language:English
Published: Dove Medical Press 2017-05-01
Series:International Journal of COPD
Subjects:
Indacaterol
COPD
Tuberculosis
Airflow limitation
Lungs
Online Access:https://www.dovepress.com/inhaled-indacaterol-for-the-treatment-of-copd-patients-with-destroyed--peer-reviewed-article-COPD

Internet

https://www.dovepress.com/inhaled-indacaterol-for-the-treatment-of-copd-patients-with-destroyed--peer-reviewed-article-COPD

Similar Items